Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METASUN: Metabonomics/Lipidomics in mRCC
NCT02570789Phase 4Terminated
- Start
- Dec 2012
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sunitinib, pazopanib in clear cell renal cell carcinoma (ccRCC). Started Dec 2012; status: terminated.
02
Drugs
sunitinibpazopanib
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT02570789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570789.